HEALWARE
DRUG RISK INTELLIGENCE
Hong Kong • London
Color mood
AI ALLERGY & ONCOLOGY INTELLIGENCE
From molecule
to safer
treatment

Healware reads drugs as molecules, not just names. We turn structures, labels and case reports into a graph of allergy and toxicity risk that clinicians can read in seconds.

From chemotherapy and supportive drugs to everyday prescriptions, Healware highlights hidden cross-reactions, suggests safer options and keeps the focus on what matters most — the patient in front of you.

HERO
First touch with Healware
ALLERGY CHECKER
Graph neural risk model
Molecular graph
Each drug is represented as a graph where atoms are nodes and bonds are edges. This lets us reason about allergy risk at the structure level, not just by name.
Graph neural model
A graph neural network propagates signals across the molecule, highlighting fragments associated with known reactions and cross-allergies.
Cross-reactivity map
Similar fragments across different drugs are linked, creating a network where hidden relationships and potential risks become visible.
TCM BRIDGE
From herbal formulas to oncology signals
Healware connects traditional Chinese medicine patterns with modern cancer biomarkers, toxicity profiles and evidence-based treatment decisions.
Pattern-based view
TCM describes patients through patterns – heat, dampness, stagnation. We encode these patterns as structured clinical features instead of free text.
Oncology-grade data
Lab values, imaging reports and treatment regimens are normalized into one schema, aligned with oncology guidelines and toxicity grades.
Bridge engine
A mapping layer links herbal formulas, active compounds and known mechanisms to modern cancer pathways, safety evidence and drug interactions.
TCM
Bridge
Oncology
Step 01
Extract TCM pattern & herbal formula.
Step 02
Map compounds to molecular targets.
Step 03
Align with cancer biomarkers, toxicity and drug-drug interactions.
milestones
Where Healware Stands Today
A fast-growing AI venture across London and Hong Kong, backed by clinical expertise, scientific validation, and global tech ecosystems.
HKSTP INCUBATION
Selected for Hong Kong Science & Technology Park incubation program. Access to labs, mentorship, deep-tech network, and Asia’s leading innovation hub.
RESEARCH AWARD
Winner of *Best Scientific Work* at a regional medical conference for early allergy data modelling research and clinical risk mapping in Ukraine.
AWS TECHFEST
Presented Healware’s AI pipeline and graph-based allergy predictor at AWS team. Recognized for innovation in medical AI workflows.
ABOUT US

People behind Healware

Healware is built by two founders working across London and Hong Kong. We combine engineering, oncology and applied AI to bring structure to drug-safety data, uncover hidden cross-reactions and design tools that clinicians can trust.

Ekaterina
Kate Baleiko
Co-founder • CEO

UCL Computer SCience

LinkedIn
Joyce Kong
Joyce Kong
Co-founder • CTO

UCL Computer Science

LinkedIn

CONTACT

Let's build something meaningful

Whether it’s partnerships, investment, collaboration or research, we’d love to connect.

HEALWARE • DRUG RISK INTELLIGENCE
Healware UI screenshot